Trends & Forecasts

Analytical QbD (AQbD) promises to extend the rigor and benefits of QbD into the area of analytical method development.

When it comes to IP, large companies regularly trample over the rights of smaller firms.

Sitting Down With... Dirk Sauer, Novartis’ Global Head, Development Franchise Ophthalmics.

To launch a new company, you’ll need great science…and great perseverance.

Using tiny imperfections in the printing process to track individual products through the supply chain

It’s the timeless story: Teva wants Mylan, Mylan wants Perrigo, and Perrigo wants none of it

Celebrating medicine makers of all stripes in our Top 100, we present The Medicine Maker Power List 2015!

The potential for growth is huge, but how do you break into the market?

The first US biosimilar has been pocketed and the game is on. We bring six experts to the table to discuss the impact on industry dynamics.

Without proper supply chain management, efforts to supply drugs to the developing world are wasted.